Cannabis advocacy organization NORML has released an updated and revised version of “Clinical Applications for Cannabis & Cannabinoids: A Review of the Recent Scientific Literature, 2000-2021,” which includes reviews of more than 450 peer-reviewed studies related to the safety and therapeutic efficacy of cannabis.
The previous version of the book was issued in 2017 and, since then, NORML says there have been “thousands of studies relevant to the medicinal properties of cannabis.”
“NORML has long advocated for the enactment of evidence-based marijuana policies. When it comes to addressing questions specific to the safety and therapeutic efficacy of cannabis, this publication provides the evidence that patients and their physicians — as well as lawmakers — need to know.” — NORML Deputy Director Paul Armentano, the book’s chief author, in a statement
The book is currently listed as the top new release in the medical research category on Amazon, where it is available for the Kindle for $5.99. Proceeds from the book are used to fund NORML’s advocacy efforts directly.
In 2020, NORML notes, researchers worldwide published a record 3,500-plus scientific papers on cannabis, according to data compiled by the National Library of Medicine and PubMed.gov. So far this year, there have been over 3,600 papers published on the topic and, in all, PubMed now cites over 38,000 scientific papers on cannabis, the organization said in a press release.
A soft-cover version of the book is also available for pre-order on the NORML website for $12.00.
Get daily cannabis business news updates. Subscribe